CSIMarket


Cvs Health Corporation  (CVS)
Other Ticker:  
 


 

Cvs Health Corporation

CVS's Financial Statements and Analysis



Cvs Health Corporation reported in the first quarter of 2024 net earnings per share of $0.88 a decrease by -46.67 % year on year from $1.65 and decline of -44.65 % from $1.59 earned in IV. Quarter (Dec 31 2023).


first quarter of 2024
Earnings Per Share Revenues
$ 0.88 $  88,437 Mill
$-0.77     -46.67 % $+3,159M     +3.7 %



Cvs Health's Revenue rose by 3.7 % in first quarter of 2024 (Mar 31 2024) year on year, to $88,437 million and declined by -5.73 % sequentially.


Cvs Health is

More on CVS's Income Statement



Cvs Health 's net income of $1,124.000 million in the first quarter of 2024 decreased by -47.53 % from net earnings of $2,142.000 million achieved in I. Quarter a year ago.

Sequentially net earnings fell by -45.09 % from net income of $2,047.000 million realized in previous quarter.

More on CVS's Growth



Cvs Health Inventories
Inventories declined by -10.5 % to $16,346.00 million from I. Quarter a year ago, sequentially inventories fell by -9.31 %. CVS's Cash flow In the first quarter of 2024 company's net cash flow was $1,582 million, capital expenditures grew by -984-28.35%, to $-705 millions compare to same quarter a year ago

More on CVS's Cash flow Statement


Cvs Health Corporation payed out dividend of $2.48 per share in last 52 weeks representing 43.51 % of net earning per share in trailing twelve-month period.

During the same period Cvs Health Corporation earned $ 8.60 cash per share, on a free-cash flow basis 150.81 % of net earning per share.

Book value fell by -1.51 % sequentially to $58.52 per share.
Tangible Book value fell to $ -36.22 per share from $ -34.02.

Company repurchased 22.64 million shares or 1.76 % in Mar 31 2024.
Interest Coverage Ratio was 4.55. Debt Coverage Ratio was 0.2.

More on CVS's Dividends

 Market Capitalization (Millions) 72,776
 Shares Outstanding (Millions) 1,267
 Total Debt (Millions $) 64,144
 Revenue (TTM) (Millions $) 360,935
 Net Income (TTM) (Millions $) 7,350
 Cash Flow (TTM) (Millions $) -4,848
 Capital Exp. (TTM) (Millions $) -2,752
 Dividend TTM ($) 2.48 $
 Dividend Yield TTM (%) 4.63 %
 Employees (TTM) $ 300,000




Cvs Health Corporation payed out dividend of $2.48 per share in the last 52 weeks representing 43.51 % of net earning per share in trailing twelve-month period.

During the same period Cvs Health Corporation had $ 8.60 cash flow per share, on a free-cash flow basis 150.81 % of net earning per share.

Book value fell by -1.51 % sequentially to $58.52 per share.
Tangible Book value fell to $ -36.22 per share from $ -34.02.

Company repurchased 22.64 million shares or 1.76 % in Mar 31 2024.
Interest Coverage Ratio was 4.55. Debt Coverage Ratio was 0.2.

More on CVS's Balance Sheets

 Market Capitalization (Millions) 72,776
 Shares Outstanding (Millions) 1,267
 Total Debt (Millions $) 64,144
 Revenue (TTM) (Millions $) 360,935
 Net Income (TTM) (Millions $) 7,350
 Cash Flow (TTM) (Millions $) -4,848
 Capital Exp. (TTM) (Millions $) -2,752
 Dividend TTM ($) 2.48 $
 Dividend Yield TTM (%) 4.63 %
 Employees (TTM) $ 300,000
   


  News about Cvs Health Corporation Earnings

CVS Health Corporation's Revenue Growth Surges, but Earnings Dip in Q1 2024

CVS Health Corporation, a leading healthcare company, has reported its financial results for the first quarter of 2024. Despite an increase in revenue, the company disclosed a decline in earnings per share (EPS). Revenue grew by 3.704% to $88.44 billion compared to $85.28 billion in the same period last year. However, net profit per share plummeted by -46.67% to $0.88 per share, compared to $1.65 per share in the corresponding period a year ago.
Although CVS's revenue growth was below that of its peers in the Pharmacy Services and Retail Drugstore industry, it still reported a 12.76% improvement compared to the same period last year. In the previous reporting period, CVS Health Corporation achieved reven...

CVS Health Corporation Sees Decrease in Fourth Quarter 2023 Earnings Amidst Impressive Revenue Growth

CVS Health Corporation, a leading Pharmacy Services and Retail Drugstore company, experienced a slight decline in its shares during the month of February 2024. The shares dropped by -0.22%, bringing the year-to-date performance to -8.77%. Currently trading on the NYSE, CVS Health Corporation's shares are valued at 1% above its 52-week average.
During the period from October to December 2023, CVS Health Corporation witnessed a reduction in its earnings per share (EPS) despite a significant increase in revenue. The profitability decreased by -9.26% to $1.59 per share, while the revenue grew extensively by 11.887% to $93.81 billion compared to the same period the previous year. This growth in revenue outpac...

CVS Health Corporation emerges as industry leader with impressive revenue growth in Q3 2023

CVS Health Corporation, a leading player in the Pharmacy Services and Retail Drugstore sector, has bucked the trend of declining orders and fading revenue that has plagued many companies in the industry. In its fiscal third quarter of 2023, the company reported positive profits of $1.75 per share, a significant improvement from the loss of $2.60 per share in the same period last year. This represents a commendable turnaround for CVS Health Corporation.
Net profit per share also saw a healthy increase of 18.24% from the prior financial reporting period, reaching $1.48 per share. Additionally, the company witnessed a notable growth of 10.603% in revenue, which amounted to $89.76 billion compared to $81.16 ...

CVS Health Corporation Witnesses Noteworthy EPS Decline Amid Enhanced Revenue Performance in Q2 2023, Despite Outpacing Pharmacy Services & Retail Drugstore Industry

As a stock market journalist, I have been closely following the financial results of CVS Health Corporation. In the second quarter of 2023, CVS experienced a reduction in earnings per share (EPS) despite a respectable growth in revenue. The net profit per share dropped by -33.63% to $1.48 per share, while revenue increased by 10.275% to $88.92 billion compared to the same quarter last year.
However, it is important to note that CVS Health Corporation has managed to outperform its industry contemporaries in terms of revenue growth. While the Pharmacy Services and Retail Drugstore industry showed a 9.87% revenue growth during the same period, CVS saw a higher growth rate of 10.275%. This signifies the comp...

CVS Health Corporation Faces Surprise Earnings Tumble Amidst Record-breaking Revenue Surge

CVS Health Corporation is a well-known name in the healthcare industry. With a focus on providing healthcare services and products to millions of people across the United States, CVS Health Corporation has become one of the largest integrated pharmacy chains in the world. However, the most recent financial analysis reveals that CVS Health Corporation has confronted a reduction in EPS, despite revenue elevation in the most recent fiscal period.
In the most recent fiscal period, CVS Health Corporation reported that profits decreased by -5.17% to $1.65 per share, despite an impressive increase in revenue by 11.001% to $85.28 billion, from the comparable financial reporting period a year ago. Compared to the...


Date modified: 2024-05-01T23:15:10+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com